| 1 | Approve Financial Statements | For |
| 2 | Discharge the Board and the Auditors | Oppose |
| 3 | Election of the members of the new Board of Directors as the term of the existing Board expires | Oppose |
| 4 | Elect Audit Committee | Abstain |
| 5 | Approve distribution of Company Earnings and of the dividend for the fiscal year 2025 (EUR 1.40) | For |
| 6 | Appoint the Auditors (KPMG) and authorise the board to fix their remuneration | Oppose |
| 7 | Approve for the board directors for the financial year 2025 and pre-approval of their fees for the financial year 2026 | Abstain |
| 8 | Approval for advance payment of fees to Board members for the period until the next Annual Ordinary General Assembly pursuant to Article 109 of the Law 4548/2018 | Oppose |
| 9 | Distribution of part of the Net Income of the fiscal year 2025 to the members of the Board and senior executives of the Company and granting of the relevant authorisations | Oppose |
| 10 | Distribution of part of the Net Income of the fiscal year 2025 to the Company personnel and granting of the relevant authorisations | Oppose |
| 11 | Early termination of the Share Buyback program approved by the Annual Ordinary General Meeting of 18 June 2025 | For |
| 12 | Approve a Share Buyback program in accordance with Article 49 of Law 4548/2018, as it is in force and grant the relevant authorisations | Oppose |
| 13 | Amendment of the Board of Directors' Suitability Policy according to Article 3 of the Law 4706/2020 | Oppose |
| 14 | Submission for discussion at the General Assembly of the report of the Board of Directors' Remuneration Report for the fiscal year 2025 | Oppose |
